Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Adipocyte Mineralocorticoid Receptor.

Infante M, Armani A, Marzolla V, Fabbri A, Caprio M.

Vitam Horm. 2019;109:189-209. doi: 10.1016/bs.vh.2018.10.005. Epub 2018 Dec 21. Review.

PMID:
30678856
2.

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice.

Marzolla V, Armani A, Mammi C, Feraco A, Caprio M.

J Vis Exp. 2018 Sep 26;(139). doi: 10.3791/58303.

PMID:
30320746
3.

Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease.

Gorini S, Marzolla V, Mammi C, Armani A, Caprio M.

Biomolecules. 2018 Sep 18;8(3). pii: E96. doi: 10.3390/biom8030096. Review.

4.

Minor role of mature adipocyte mineralocorticoid receptor in high fat induced obesity.

Feraco A, Armani A, Urbanet R, Nguyen Dinh Cat A, Marzolla V, Jaisser F, Caprio M.

J Endocrinol. 2018 Aug 18. pii: JOE-18-0314. doi: 10.1530/JOE-18-0314. [Epub ahead of print]

PMID:
30121579
5.

Inhibition of Vascular c-Jun N-Terminal Kinase 2 Improves Obesity-Induced Endothelial Dysfunction After Roux-en-Y Gastric Bypass.

Doytcheva P, Bächler T, Tarasco E, Marzolla V, Engeli M, Pellegrini G, Stivala S, Rohrer L, Tona F, Camici GG, Vanhoutte PM, Matter CM, Lutz TA, Lüscher TF, Osto E.

J Am Heart Assoc. 2017 Nov 14;6(11). pii: e006441. doi: 10.1161/JAHA.117.006441.

6.

Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

Marzolla V, Armani A, Mammi C, Moss ME, Pagliarini V, Pontecorvo L, Antelmi A, Fabbri A, Rosano G, Jaffe IZ, Caprio M.

Int J Cardiol. 2017 Apr 1;232:233-242. doi: 10.1016/j.ijcard.2017.01.013. Epub 2017 Jan 5.

7.

Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology.

Armani A, Marzolla V, Fabbri A, Caprio M.

J Mol Endocrinol. 2015 Oct;55(2):R1-10. doi: 10.1530/JME-15-0122. Epub 2015 Aug 13. Review.

PMID:
26272942
8.

Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome.

Marzolla V, Armani A, Feraco A, De Martino MU, Fabbri A, Rosano G, Caprio M.

Steroids. 2014 Dec;91:46-53. doi: 10.1016/j.steroids.2014.05.001. Epub 2014 May 10. Review.

PMID:
24819992
9.

Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.

Armani A, Cinti F, Marzolla V, Morgan J, Cranston GA, Antelmi A, Carpinelli G, Canese R, Pagotto U, Quarta C, Malorni W, Matarrese P, Marconi M, Fabbri A, Rosano G, Cinti S, Young MJ, Caprio M.

FASEB J. 2014 Aug;28(8):3745-57. doi: 10.1096/fj.13-245415. Epub 2014 May 7.

PMID:
24806198
10.

The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism.

Marzolla V, Armani A, Zennaro MC, Cinti F, Mammi C, Fabbri A, Rosano GM, Caprio M.

Mol Cell Endocrinol. 2012 Mar 24;350(2):281-8. doi: 10.1016/j.mce.2011.09.011. Epub 2011 Sep 10. Review.

PMID:
21945603
11.

Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?

Armani A, Marzolla V, Rosano GM, Fabbri A, Caprio M.

Trends Endocrinol Metab. 2011 Oct;22(10):404-11. doi: 10.1016/j.tem.2011.05.004. Epub 2011 Jul 7. Review.

PMID:
21741267
12.

Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.

Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, Marzolla V, Fabbri A, Zennaro MC, Fève B.

Endocrinology. 2011 Jan;152(1):113-25. doi: 10.1210/en.2010-0674. Epub 2010 Nov 17.

PMID:
21084448
13.

Cellular models for understanding adipogenesis, adipose dysfunction, and obesity.

Armani A, Mammi C, Marzolla V, Calanchini M, Antelmi A, Rosano GM, Fabbri A, Caprio M.

J Cell Biochem. 2010 Jun 1;110(3):564-72. doi: 10.1002/jcb.22598. Review. Erratum in: J Cell Biochem. 2010 Nov 1;111(4):1074.

PMID:
20512917

Supplemental Content

Loading ...
Support Center